OIG Says Medicare Spending On Testing Increased in 2019

Savings from PAMA Price Cuts Exceeded by More Spending on Genetic Tests

Share on facebook
Share on twitter
Share on linkedin
Share on print
Share on email
CEO SUMMARY: Newly-released data indicates that Medicare officials are falling far short of their goal to decrease the total amount of money spent annually on Part B clinical laboratory tests. That is one finding by the federal Office of the Inspector General in its report of Medicare lab test spending during 2019. Despite deep cuts …

OIG Says Medicare Spending On Testing Increased in 2019 Read More »

This post is only available to members.

Comments

;

You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

Privacy Policy: We will never share your personal information.